The Two Sessions are the country's most important legislative meetings of the year and set China's government budgets, domestic and international policy priorities, and economic targets. What is the outlook of for China domestically and internationally? How does it affect foreign businesses in China? What should businesses and industries look out for?
AmCham Shanghai Hangzhou Center is pleased to welcome Anne Wang, Chief Operating Officer, Greater China, APCO Worldwide to give a readout of this year's Lianghui meetings on Thursday, Mar 23 2PM-3:30 PM. The presentation will discuss key political and economic takeaways, also with a focus on the policies related to biopharmaceuticals and medical devices.
Lilian Liang is Stryker China Vice President, Government Affairs & Market Access, and reports to John Collins, Stryker President, Asia Pacific. She joined Stryker China in 2019. In the past 20 years, Lilian Liang made contributions to multinational corporations in China business strategy, market access strategy, and organizational construction and talent development. Before joining Stryker, she served as the first Vice president of Government Affairs in Greater China of Danaher Group, the first Market Access Director and Chief Health Economist in Greater China and Asia-Pacific regions of GE HealthCare, and the public affairs and project manager in Pfizer China. Her current social positions include but not limited to: the foreign special member of Hangzhou Municipal Committee of the Chinese People's Political Consultative Conference, the executive director of the Hangzhou Public Diplomacy Association, the vice-chairman of the Yangtze River Delta Advisory Committee of the Shanghai American Chamber of Commerce, the vice-chairman of the Shanghai Medical Device Industry Association, and the vice-chairman of the Pharmaceutical Price Branch of the China Price Association. She has contributed to promoting bilateral business trade between China and the United States and promoting high quality development of healthcare industry in China. She has a bachelor's degree in economics, a master's degree in business administration and a master's degree in public health. She has led and participated in designing and implementing multiple research projects on disease management and health economics. She has provided consultation on health resource allocation for China, Japan, Singapore, Indonesia and other countries.
Chief Operating Officer at APCO (Beijing) Consulting Company Limited
Ms. Anne Wang oversees the business operation in the Greater China region for APCO Worldwide, the second largest privately owned public affairs consulting firms in the world. Throughout the years, she has been dedicated to fuse the best local experience with a global perspective and has built a diverse and experienced consultant team with a unique culture. In the past 10 years, Ms. Anne Wang led the company’s healthcare practice in the Greater China region and has been providing briefing and counselling on China’s macro-economic and healthcare industrial policies to global and China management teams of multinational companies as well as trade and industrial associations. With nearly 20 years of experience in public affairs, Ms. Anne Wang also provides business advisory, corporate communications, and crisis management support to enterprises in the cosmetics, education, and food sectors. Before joining APCO, Ms. Wang worked as a senior project officer in the Health Human Resources Development Center of China's National Health Commission, where she was responsible for international cooperation, policy research and capacity building programs through coordination with various partners including foreign embassies, multinational companies, international universities, and research institutions. Ms. Anne Wang holds a bachelor’s degree in clinical medicine from Tianjin Medical University and completed a master's in psychology program at the University of Essex in U.K.